IL33 and neoplasm: While in vitro and in vivo co-culture models were employed to demonstrate the effects of IL-33 on LSCC progression, the use of xenograft models or genetically engineered mouse models could provide more physiological relevance and a deeper understanding of tumor-stroma interactions in a whole-organism context.